GRTX

Q: What is the price of Galera Therapeutics (GRTX) today?

The current price of Galera Therapeutics (GRTX) is $0.11. The stock began the year trading around $0.02 and is currently priced at $0.11. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Galera Therapeutics (GRTX) pay dividends?

Galera Therapeutics (GRTX) did not pay dividends over the past year.

Galera Therapeutics Inc.

Price

$0.11

return (12m)

-98.13%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

GRTX price

Galera Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GRTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-99.38%

3 months

-98.72%

1 year

-98.13%

2 years

-99.63%

5 years

-99.99%

10 years

0.00%

Fundamentals GRTX

review the fundamentals of Galera Therapeutics shares

P/E

0.00

Sector: -4.18 Industry: -4.18

P/Revenue (PSR)

Sector: -4.11 Industry: -4.11

P/BV

0.00

Sector: 2.10 Industry: 2.10

Dividend Yield (DY)

0.00%

Sector: - Industry: -

Payout

Sector: - Industry: -

Net Profit Margins

0.00%

Sector: -39.67% Industry: -39.67%

Gross Margin

0.00%

Sector: 36.44% Industry: 36.44%

Operating Margin

0.00%

Sector: -38.52% Industry: -38.52%

EBIT Margin

Sector: - Industry: -

0.00%

Sector: - Industry: -

CAGR Profit 5 Years

0.00%

Sector: - Industry: -

FAIR VALUE OF Galera Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.11

Fair Value

$4,743,416.44

Upside Return potential.

4,517,539,369.35%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GRTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
GRTX	0.00	0.00	2,968.53%	0.00%	$0.09	0.00%
JNJ	29.36	7.61	25.92%	2.04%	$617.76 B	21.83%
PFE	18.09	1.50	8.29%	7.22%	$135.53 B	11.83%
ABBV	120.03	-65.99	-54.98%	2.73%	$436.32 B	5.79%
NVO	11.61	7.01	60.40%	3.75%	$220.17 B	37.15%
MRK	34.17	6.65	19.45%	2.72%	$305.30 B	13.59%
AZN	25.71	5.64	21.93%	1.86%	$267.10 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.68 B	30.99%
BMY	15.87	5.74	36.19%	4.41%	$115.47 B	15.01%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	15.58	2.19	14.08%	0.55%	$68.90 B	29.65%
HALO	25.79	40.96	158.82%	0.00%	$9.00 B	23.13%
AMGN	25.19	21.38	84.87%	2.69%	$196.47 B	20.96%
MCK	20.46	-116.82	-570.98%	0.41%	$97.43 B	1.18%
VRTX	28.50	6.39	22.41%	0.00%	$123.63 B	35.51%
CAH	35.40	-20.60	-58.20%	0.87%	$55.05 B	0.62%
HRMY	14.62	2.34	16.00%	0.00%	$2.13 B	16.20%
BIIB	21.22	1.56	7.36%	0.00%	$29.11 B	13.81%
MEDP	32.43	24.96	76.95%	0.00%	$14.93 B	17.19%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GRTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Galera Therapeutics

Galera Therapeutics Inc.

Average Investor10 user rating

4.0 (3 people)

United States

14 years

Founded: 2012

2019

Time since IPO - 7 years

38

Employees

Galera Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $0.09, with shareholders equity totaling $5.02 million.

The company employs approximately 38 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Galera Therapeutics Inc. reported $- in revenue, generating net income of $149.02 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GRTX.

Market cap

$0.09

Net worth

$5.02 million

$5,020,000.00

Assets

$6.16 million

$6,160,000.00

Total Shares Outstanding

1.00

000

Average Daily Trading Volume

$90.74 Thousand

$90,735.38

Sector

Health Care

Industry

Biotechnology

GRTX

GRTX revenue and profits

Financial Results GRTX

DRAG THE FRAME TO SEE MORE DATA

GRTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$809.54 14,55% (12M)

P/E

20.46

0.41%

ROE

-570.98%

P/BV

-116.82

CAH - Cardinal Health

$234.31 47,54% (12M)

P/E

35.40

0.87%

ROE

-58.20%

P/BV

-20.60

JNJ - Johnson & Johnson

$258.33 68,78% (12M)

P/E

29.36

2.04%

ROE

25.92%

P/BV

7.61

MRK - Merck & Co.

$123.50 53,06% (12M)

P/E

34.17

2.72%

ROE

19.45%

P/BV

6.65

AZN - AstraZeneca

$169.03 19,87% (12M)

P/E

25.71

1.86%

ROE

21.93%

P/BV

5.64

ABBV - AbbVie

$246.35 33,22% (12M)

P/E

120.03

2.73%

ROE

-54.98%

P/BV

-65.99

NVO - Novo Nordisk

$49.41 --24,87% (12M)

P/E

11.61

3.75%

ROE

60.40%

P/BV

7.01

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$809.54 14,55% (12 M)

P/L

20.46

0.41%

ROE

-570.98%

P/VP

-116.82

CAH - Cardinal Health

$234.31 47,54% (12 M)

P/L

35.40

0.87%

ROE

-58.20%

P/VP

-20.60

JNJ - Johnson & Johnson

$258.33 68,78% (12 M)

P/L

29.36

2.04%

ROE

25.92%

P/VP

7.61

MRK - Merck & Co.

$123.50 53,06% (12 M)

P/L

34.17

2.72%

ROE

19.45%

P/VP

6.65

AZN - AstraZeneca

$169.03 19,87% (12 M)

P/L

25.71

1.86%

ROE

21.93%

P/VP

5.64

ABBV - AbbVie

$246.35 33,22% (12 M)

P/L

120.03

2.73%

ROE

-54.98%

P/VP

-65.99

NVO - Novo Nordisk

$49.41 --24,87% (12 M)

P/L

11.61

3.75%

ROE

60.40%

P/VP

7.01

Frequently Asked Questions

What is the price of Galera Therapeutics (GRTX) today?

The current price of Galera Therapeutics (GRTX) is $0.11. The stock began the year trading around $0.02 and is currently priced at $0.11. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Galera Therapeutics (GRTX) pay dividends?

Galera Therapeutics (GRTX) did not pay dividends over the past year.

Is Galera Therapeutics (GRTX) a good investment?

Galera Therapeutics (GRTX) is currently trading at $0.11 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -98.13%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Galera Therapeutics (GRTX) stock?

You can buy Galera Therapeutics (GRTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol GRTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Galera Therapeutics (GRTX) yield today?

Over the past month, Galera Therapeutics (GRTX) has returned -99.38% — -98.13% over the past year, and -99.99% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Galera Therapeutics (GRTX) today at the current price of $0.11 your total investment would be $10.50.

Based on historical performance, the investment would have grown to approximately:

$0.20 after 1 year
$0.001050 after 5 years
$10.50 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

GRTX

Galera Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GRTX

review the fundamentals of Galera Therapeutics shares

P/E

P/Revenue (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Operating Margin

EBIT Margin

EBITDA Margin

EV/EBITDA

EV/EBIT

P/EBITDA

P/EBIT

P/Total Assets

P/Working Capital

P/Net Current Assets

BVPS

EPS

Asset Turnover

ROE

ROIC

ROA

Net Debt / Equity

Net Debt / EBITDA

Net Debt / EBIT

Gross Debt / Equity

Equity / Assets

Liabilities / Assets

Current Ratio

CAGR Revenue 5 Years

CAGR Profit 5 Years

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Galera Therapeutics

Galera Therapeutics Inc.

United States

14 years

2019

38

PROFIT X PRICE GRTX

Financial Results GRTX

GRTX cash flow

Asset, Revenue and Profit Growth - GRTX

GRTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions